In the BioHarmony Drug Report Database
Sulfacytine
Renoquid (sulfacytine) is a small molecule pharmaceutical. Sulfacytine was first approved as Renoquid on 1982-01-01. It is used to treat gram-negative bacterial infections, gram-positive bacterial infections, and urinary tract infections in the USA.
Trade Name
|
Renoquid |
|---|---|
Common Name
|
sulfacytine |
ChEMBL ID
|
CHEMBL1201056 |
Indication
|
gram-negative bacterial infections, gram-positive bacterial infections, urinary tract infections |
Drug Class
|
Antimicrobials (sulfonamides derivatives) |
Image (chem structure or protein)